Prognostic impact of systematic lymphadenectomy during interval debulking surgery after neoadjuvant chemotherapy in stage III ovarian cancer: A 38-institution retrospective cohort study using inverse probability of treatment weighting.
Sep 2026· European Journal of Surgical Oncology· Vol 52 11, pp.
112121
· 0 citations· 30 references
Medicine
TL;DR
SyLND was associated with better PFS and OS in patients with stage III ovarian cancer undergoing IDS, and pre-NACT nodal assessment may help determine the indications for SyLND during IDS.
Abstract
INTRODUCTION
We evaluated the clinical significance of systematic lymph node dissection (SyLND) during interval debulking surgery (IDS) in patients with stage III ovarian cancer, focusing on subgroups that might benefit from SyLND.
Methods
The multicenter retrospective study included patients with FIGO stage III ovarian, fallopian tube, and primary peritoneal cancers, who underwent IDS following neoadjuvant chemotherapy (NACT), at Gynecologic Cancer Study Group of the Japan Clinical Oncology Group (JCOG-GCSG) institutions between 2017 and 2021. Patients were classified into SyLND and no/selective lymph node dissection (NoLND/SeLND) groups. Progression-free survival (PFS) was the primary outcome, and overall survival (OS) and postoperative complications were secondary outcomes. Inverse probability of treatment weighting was applied.
Results
Among 696 eligible patients, SyLND was associated with better PFS (hazard ratio [HR] 0.73, 95% confidence interval [CI] 0.55-0.97) and OS (HR 0.66, 95% CI 0.48-0.92) than NoLND/SeLND. In subgroup analyses of patients achieving complete resection, SyLND yielded no survival advantage in those with clinical-negative nodes (cN0). Conversely, among patients with clinical-positive nodes (cN1) before NACT, PFS and OS favored SyLND, although differences were not statistically significant. Similar trends were observed in cN1 patients whose lymph nodes decreased to <10 mm before IDS. SyLND was associated with higher complication rates.
Conclusion
SyLND was associated with better PFS and OS in patients with stage III ovarian cancer undergoing IDS. Exploratory subgroup analyses suggested only a favorable but statistically inconclusive trend in patients with cN1. Pre-NACT nodal assessment may help determine the indications for SyLND during IDS.
Objective To investigate the controversial impact of lymphadenectomy on prognosis and postoperative complications in patients with advanced epithelial ovarian cancer (AEOC) receiving neoadjuvant chemotherapy followed by interval debulking surgery (IDS). Methods This retrospective real-world study analyzed 1068 patients...
Xing-Yu Liu, Yi-Yang Shen, Ying-Jun Zhao et al.· International Journal of Wom...· 0 citations
Objective To compare the therapeutic outcomes of neoadjuvant chemotherapy followed by interval debulking surgery (NACT-IDS) and primary debulking surgery (PDS) in patients with advanced epithelial ovarian cancer (AEOC) and to evaluate factors associated with prognosis. Methods This retrospective study included 97 patie...
Yan Ma, Meng-Li Xu, Qi Zhang et al.· Frontiers in Oncology· 0 citations
Objective This study aimed to validate the prognostic discriminatory power of the revised International Federation of Gynecology and Obstetrics (FIGO) 2018 staging system and to evaluate the association between regional lymph node resection (RLNR) and survival in cervical cancer (CC) patients who underwent RLNR followe...
Ai-Yuan Wu, R. Rezhake, Zi-Yin Huang et al.· Science in progress· 0 citations
It was indicated that LND was not associated with a survival benefit but increased surgical morbidity in patients with malignant ovarian germ cell tumors, underscoring the critical importance of timely chemotherapy.
Xin-Yang Jin, Jia-Xin Yang, Ke-Zhen Zhang et al.· Journal of Gynecologic Oncol...· 0 citations
PDS and NACT+IDS offer comparable survival outcomes in patients with advanced EOC, whereas NACT+IDS is associated with improved perioperative safety and higher tumor response rates without increasing severe chemotherapy-related toxicity.
Yong-Hui Zou, Yan-Qiu Wang, Ming-Jun Fan et al.· American Journal of Cancer R...· 0 citations
Objective To compare pathological complete response (pCR) across different neoadjuvant treatment strategies in patients with locally advanced esophageal squamous cell carcinoma (ESCC) and to identify clinicopathological factors associated with pCR. Methods In this single-center retrospective cohort study, 247 consecuti...
Xiao-Li Yuan, Yu-Ying Liang, T. Han et al.· Frontiers in Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.